Perspective Therapeutics (CATX) Inventory Average (2011 - 2023)
Perspective Therapeutics (CATX) reported Inventory Average of $1.1 million for Q3 2023, down 28.55% on a YoY basis from $1.5 million in Q3 2022, and down 15.79% sequentially from $1.3 million in Q2 2023.
Perspective Therapeutics (CATX) Inventory Average (2011 - 2023) Analysis & Trends
Perspective Therapeutics (CATX) has 12 years of Inventory Average data on file, last reported at $1.1 million in Q3 2023.
- For the quarter ending Q3 2023, Inventory Average fell 28.55% year-over-year to $1.1 million; the trailing twelve-month figure through Sep 2023 stood at $1.1 million (down 28.55% YoY), and the FY2022 full-year result was $1.4 million, changed N/A from the prior year.
- Inventory Average fell to $1.1 million in Q3 2023, from $1.3 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $1.5 million in Q4 2022 to a low of $513500.0 in Q1 2019.
- A 5-year average of $908184.2 and a median of $855500.0 in 2021 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average jumped 62.94% in 2021 and decreased 28.55% in 2023, its largest moves.
- Tracing CATX's Inventory Average over 5 years: stood at $523000.0 in 2019, then climbed by 24.86% to $653000.0 in 2020, then jumped by 62.94% to $1.1 million in 2021, then jumped by 39.19% to $1.5 million in 2022, then decreased by 28.87% to $1.1 million in 2023.
- Business Quant data shows CATX's Inventory Average at $1.1 million in Q3 2023, $1.3 million in Q2 2023, and $1.4 million in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 5.36 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.13 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.12 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 661.35 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.49 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 2.29 Bn |
| 10 | Perspective Therapeutics | 146.05 Mn | 146.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 1.25 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.48 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 1.28 Mn |
| Mar 31, 2022 | 1.12 Mn |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 855,500.00 |
| Mar 31, 2021 | 698,000.00 |
| Dec 31, 2020 | 653,000.00 |
| Sep 30, 2020 | 643,000.00 |
| Jun 30, 2020 | 612,500.00 |
| Mar 31, 2020 | 562,500.00 |
| Dec 31, 2019 | 523,000.00 |
| Sep 30, 2019 | 515,500.00 |
| Jun 30, 2019 | 531,500.00 |
| Mar 31, 2019 | 513,500.00 |
| Dec 31, 2018 | 490,500.00 |